Scenarios that move VSTM
Verastem, Inc. - Common Stock
Scenarios that move VSTM: 1 analysis, 0 positive, 1 negative.
- · CHMP backs CORT's Lifyorli combo for ovarian cancer — ▼ · impact -12 · confidence low · horizon quarters
Verastem, Inc. - Common Stock
Scenarios that move VSTM: 1 analysis, 0 positive, 1 negative.